These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States. Trent JT, Kirsner RS, Romanelli P, Kerdel FA. Arch Dermatol; 2004 Jul; 140(7):890-2. PubMed ID: 15262712 [No Abstract] [Full Text] [Related]
7. Toxic epidermal necrolysis probably due to Klebsiella pneumoniae sepsis. de Groot R, Oranje AP, Vuzevski VD, Mettau JW. Dermatologica; 1984 Jul; 169(2):88-90. PubMed ID: 6383893 [Abstract] [Full Text] [Related]
8. Toxic epidermal necrolysis induced by levofloxacin. Davila G, Ruiz-Hornillos J, Rojas P, De Castro F, Zubeldia JM. Ann Allergy Asthma Immunol; 2009 May; 102(5):441-2. PubMed ID: 19492670 [No Abstract] [Full Text] [Related]
9. Toxic epidermal necrolysis secondary to vancomycin. Chan-Tack K. Mo Med; 2000 Apr; 97(4):131-2. PubMed ID: 10790986 [No Abstract] [Full Text] [Related]
10. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis]. van der Meer JB. Ned Tijdschr Geneeskd; 1996 Jul 27; 140(30):1538-43. PubMed ID: 8765761 [No Abstract] [Full Text] [Related]